Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Home Care for Children with Sickle Cell Disease
source: UC Health
summary/abstract:Sickle cell disease is an inherited disorder in which red blood cells become C-shaped. This causes impaired blood flow, pain, and other health problems. Symptoms usually show up by about 5 months of age.
Although a child who has sickle cell disease should be under a healthcare provider’s care, parents can do many things at home to reduce symptoms and maintain the child’s health.
Take these steps to prevent infections:
-Contagious diseases like the flu can be dangerous for children with sickle cell disease. They, as well as their caregivers and family members, should wash their hands several times a day with soap and water to reduce the spread of the flu virus and other germs.
-Children with sickle cell disease are also vulnerable to illness from a bacterium called salmonella. To avoid salmonella, they should avoid eating raw or undercooked meats and eggs.
-They should also avoid touching reptiles. They can carry the bacterium.
-Make sure your child’s immunizations are up to date.
read more
+myBinderRelated Content
-
FDA Awards $2M to Phase 2 Trial of Vitamin D for Reducing Risk of SCD Respiratory ComplicationsThe U.S. Food and Drug Administration (F...
-
Red blood cell transfusion to treat or prevent complications in sickle cell disease: An overview of Cochrane reviewsBackground: Globally, sickle cell disea...
-
Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occ...Hydroxyurea (HU) is approved in EU and U...
-
Sickle Cell Treatment Endari Now Available in the United StatesEmmaus Life Sciences has announced that ...
-
Georgia Universities Join NIH-funded National Study of Bone Marrow Transplant for SCDThe Medical College of Georgia (MCG) and...
-
Facebook Live: Stem Cells and Sickle Cell Diseasehttps://www.youtube.com/watch?v=IPzNx8i_...
-
Endari reduces pain crises, hospitalizations in sickle cell patients, phase 3 trial showsTreatment with Endari (L-glutamine) le...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.